These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 36995338

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Promotion of osteoclastogenesis by IL-26 in rheumatoid arthritis.
    Lee KA, Kim KW, Kim BM, Won JY, Min HK, Lee DW, Kim HR, Lee SH.
    Arthritis Res Ther; 2019 Dec 12; 21(1):283. PubMed ID: 31831038
    [Abstract] [Full Text] [Related]

  • 3. Inhibitory effect and mechanism of 1,25-dihydroxy vitamin D3 on RANKL expression in fibroblast-like synoviocytes and osteoclast-like cell formation induced by IL-22 in rheumatoid arthritis.
    Wen H, Liu Y, Li J, Wei D, Liu D, Zhao F.
    Clin Exp Rheumatol; 2018 Dec 12; 36(5):798-805. PubMed ID: 29465363
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interleukin-35 upregulates OPG and inhibits RANKL in mice with collagen-induced arthritis and fibroblast-like synoviocytes.
    Li Y, Li D, Li Y, Wu S, Jiang S, Lin T, Xia L, Shen H, Lu J.
    Osteoporos Int; 2016 Apr 12; 27(4):1537-1546. PubMed ID: 26572759
    [Abstract] [Full Text] [Related]

  • 9. Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6.
    Dickerson TJ, Suzuki E, Stanecki C, Shin HS, Qui H, Adamopoulos IE.
    J Autoimmun; 2012 Dec 12; 39(4):369-76. PubMed ID: 22867712
    [Abstract] [Full Text] [Related]

  • 10. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand.
    Lee CK, Lee EY, Chung SM, Mun SH, Yoo B, Moon HB.
    Arthritis Rheum; 2004 Dec 12; 50(12):3831-43. PubMed ID: 15593184
    [Abstract] [Full Text] [Related]

  • 11. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.
    Pettit AR, Walsh NC, Manning C, Goldring SR, Gravallese EM.
    Rheumatology (Oxford); 2006 Sep 12; 45(9):1068-76. PubMed ID: 16490750
    [Abstract] [Full Text] [Related]

  • 12. Activity of fibroblast-like synoviocytes in rheumatoid arthritis was impaired by dickkopf-1 targeting siRNA.
    Liu YY, Wang SY, Li YN, Bian WJ, Zhang LQ, Li YH, Long L, Liu X, Zhang XW, Li ZG.
    Chin Med J (Engl); 2020 Mar 20; 133(6):679-686. PubMed ID: 32068606
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.
    Ohtsuji M, Lin Q, Nishikawa K, Ohtsuji N, Okazaki H, Tsurui H, Amano H, Shirai T, Nishimoto N, Nishimura H, Hirose S.
    Mod Rheumatol; 2015 Mar 20; 25(2):270-7. PubMed ID: 25159156
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of hormone and cytokine-stimulated osteoclastogenesis and bone resorption by interleukin-4 and interleukin-13 is associated with increased osteoprotegerin and decreased RANKL and RANK in a STAT6-dependent pathway.
    Palmqvist P, Lundberg P, Persson E, Johansson A, Lundgren I, Lie A, Conaway HH, Lerner UH.
    J Biol Chem; 2006 Feb 03; 281(5):2414-29. PubMed ID: 16251181
    [Abstract] [Full Text] [Related]

  • 16. miR-145-5p Increases Osteoclast Numbers In Vitro and Aggravates Bone Erosion in Collagen-Induced Arthritis by Targeting Osteoprotegerin.
    Chen Y, Wang X, Yang M, Ruan W, Wei W, Gu D, Wang J, Guo X, Guo L, Yuan Y.
    Med Sci Monit; 2018 Jul 30; 24():5292-5300. PubMed ID: 30059491
    [Abstract] [Full Text] [Related]

  • 17. CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis.
    Tsushima H, Okazaki K, Ishihara K, Ushijima T, Iwamoto Y.
    Arthritis Res Ther; 2015 Feb 17; 17(1):31. PubMed ID: 25811130
    [Abstract] [Full Text] [Related]

  • 18. TLR-3 enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis.
    Kim KW, Cho ML, Oh HJ, Kim HR, Kang CM, Heo YM, Lee SH, Kim HY.
    Immunol Lett; 2009 May 14; 124(1):9-17. PubMed ID: 19446344
    [Abstract] [Full Text] [Related]

  • 19. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.
    Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, Koshihara Y, Oda H, Nakamura K, Tanaka S.
    Arthritis Rheum; 2000 Feb 14; 43(2):259-69. PubMed ID: 10693864
    [Abstract] [Full Text] [Related]

  • 20. RhoA Promotes Synovial Proliferation and Bone Erosion in Rheumatoid Arthritis through Wnt/PCP Pathway.
    Chen N, Diao CY, Huang X, Tan WX, Chen YB, Qian XY, Gao J, Zhao DB.
    Mediators Inflamm; 2023 Feb 14; 2023():5057009. PubMed ID: 38022686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.